Commentary from a research paper published in the American Journal of Ophthalmology has cautioned clinicians to be both realistic and hopeful in their communications with… Read More »Journal paper advises caution among clinicians in communicating the potential benefits and timelines for ocular gene therapy
A Phase Ib/IIa clinical trial has reportedly treated the first macular edema patient with a novel delivery system designed to increase compliance and improve drug… Read More »Safety and efficacy of ocular iontophoresis with dexamethasone solution undergoes clinical testing with novel delivery system
Phase II clinical trial data from a study of integrin peptide therapy (referenced as “ALG-1001” or “Luminate”), conducted in 106 patients with vitreomacular traction (VMT)… Read More »Phase II clinical trial data on novel integrin therapy for VMT indicates statistical improvement over placebo
An expert panel of clinical ophthalmologists, assembled in London by Bayer HealthCare, has issued recommendations in relation to the administration of aflibercept (Eylea) in wet… Read More »UK expert panel publish recommendations on use of aflibercept after year 1
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of marketing authorisation for “Raxone” (idebenone), a novel… Read More »EMA’s CHMP recommends first authorisation for Leber’s Hereditary Optic Neuropathy treatment
A Phase II a human study led by retinal clinicians at the Retinal Consultants of Arizona in Phoenix, and sponsored by Acucela Inc., based in… Read More »Phase II clinical study of emixustat hydrochloride for treatment of geographic atrophy shows dose-dependent effect
Collaborative clinical research led by the Department of Ophthalmology, Odense University Hospital, Denmark has indicated that approximately 12.0% of type-1 diabetes patients over a 17-year… Read More »Clinical study highlights long-term incidence of vitrectomy in patients with type-1 diabetes
Clinical research from the Nuffield Department of Population Health, University of Oxford, has shown a considerable increase in the annual number of retinal detachments recorded… Read More »Retinal detachment increases in England in association with the incidence of diabetes
A recent publication on clinical trial results arising from industry-sponsored head-to-head studies has concluded that problems continue to persist with industry-funded studies. The analysis, led… Read More »Analysis of head to head comparative clinical trials sponsored by industry show strong association with favourable results
Clinical research led by a Japanese team at Kyushu University Graduate School of Medical Sciences, Fukuoka, has suggested that overexpression of CD163 in the vitreous… Read More »Biomarker involved in proliferative diabetic retinopathy (PDR) highlights potential role of M2 macrophage